Prescription Required
It is unsafe to consume alcohol with Blomig P 10 mg/5 mg/325 mg Tablet.
Blomig P 10 mg/5 mg/325 mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Information regarding the use of Blomig P 10 mg/5 mg/325 mg Tablet during breastfeeding is not available. Please consult your doctor.
Blomig P 10 mg/5 mg/325 mg Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Blomig P 10 mg/5 mg/325 mg Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Blomig P 10 mg/5 mg/325 mg Tablet may not be needed in these patients. Please consult your doctor.
Blomig P 10 mg/5 mg/325 mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Blomig P 10 mg/5 mg/325 mg Tablet may be needed. Please consult your doctor.<BR>However, the use of Blomig P 10 mg/5 mg/325 mg Tablet is not recommended in patients with severe liver disease and active liver disease.
Blomig P 10 mg/5 mg/325 mg Tablet is a combination of three medicines: Domperidone, Flunarizine and Paracetamol/Acetaminophen which prevent migraine accompanied by nausea/vomiting. Domperidone is an antiemetic and prokinetic which blocks the action of a dopamine (a chemical messenger) in the brain which causes nausea and vomiting. Flunarizine is a calcium channel blocker which works by preventing the narrowing of blood vessels in the head thereby preventing migraine headache. Paracetamol is an analgesic (pain reliever) and antipyretic (fever reducer). It blocks the release of certain chemical messengers in the brain that are responsible for pain.
Prescription Required
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHA